FRID MIND TECHNOLOGIES
ActiveSummary
FRID MIND TECHNOLOGIES has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €817,176 and a net result of -€75,045. Equity is shrinking by ~16.4% per year across the filed fiscal years. Its solvency ranks better than 69% of 264 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
06-07
State Gazette act
Resignations: Marc Nolet, Pierre Lefebvre and René-Pierre AzriaShare transfer · Director discharge11 facts ▸
State Gazette act
Resignations: Marc Nolet, Pierre Lefebvre and René-Pierre Azria
Share transfer · Director discharge11 facts ▸
- General meeting, 28-08-2025
- Director resignation, Marc Nolet (director)
- Director resignation, Pierre Lefebvre (director)
- Director resignation, René-Pierre Azria (director)
- Share transfer, Marc Nolet → Bioradmedisys
- Share transfer, Pierre Lefebvre → Bioradmedisys
- Share transfer, René-Pierre Azria → Bioradmedisys
- Director discharge, Marc Nolet
- Director discharge, Pierre Lefebvre
- Director discharge, René-Pierre Azria
- Director in office, Noureddine Frid (director)
24-06
State Gazette act
Resignations: Marc Nolet, Pierre Lefebvre and René-Pierre AzriaShare transfer · Director discharge · Registered-office move16 facts ▸
State Gazette act
Resignations: Marc Nolet, Pierre Lefebvre and René-Pierre Azria
Share transfer · Director discharge · Registered-office move16 facts ▸
- General meeting, 28-08-2025
- Director resignation, Marc Nolet (director)
- Director resignation, Pierre Lefebvre (director)
- Director resignation, René-Pierre Azria (director)
- Share transfer, Marc Nolet → Bioradmedisys
- Share transfer, Pierre Lefebvre → Bioradmedisys
- Share transfer, René-Pierre Azria → Bioradmedisys
- Director discharge, Marc Nolet (director)
- Director discharge, Pierre Lefebvre (director)
- Director discharge, René-Pierre Azria (director)
- Board meeting, 10-06-2026
- Registered-office move, Rue Sart-Saint-Nicolas 44 à 6001 Charleroi
- +4 further facts in this act
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
09-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity quadruplescurrent ratio 1.65
Current ratio from 0.39 to 1.65; short-term debt falls from €428,773 to €213,032.
31-12
Financial
Equity above €1mEq €1.1m ▲33.4%
Equity rises from €801,036 to €1.1m.
13-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet -€517,802
Net result drops to -€517,802, the lowest in the series; recovery starts the following year.
13-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 13 days late
2020
11-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 133 days late
Show earlier events
2019
08-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
13-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
17-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
2 of 7 acts read
About the unread acts
Of the 7 Belgian State Gazette acts we know for this company, 2 have been read. The other 5 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.